157 related articles for article (PubMed ID: 867045)
21. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
[TBL] [Abstract][Full Text] [Related]
22. Conformationally restricted bicyclic analogs of somatostatin.
Veber DF; Holly FW; Paleveda WJ; Nutt RF; Bergstrand SJ; Torchiana M; Glitzer MS; Saperstein R; Hirschmann R
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2636-40. PubMed ID: 208068
[TBL] [Abstract][Full Text] [Related]
23. A super active cyclic hexapeptide analog of somatostatin.
Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG
Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233
[TBL] [Abstract][Full Text] [Related]
24. Development of specific and non-specific somatostatin analogs.
Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological actions of prosomatostatin.
Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH
Peptides; 1982; 3(5):811-4. PubMed ID: 6129618
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of glucagon and insulin secretion by somatostatin analogs.
Voyles NR; Bhathena SJ; Recant L; Meyers CA; Coy DH
Proc Soc Exp Biol Med; 1979 Jan; 160(1):76-9. PubMed ID: 419132
[No Abstract] [Full Text] [Related]
28. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of rat pancreatic A and B cells to somatostatin.
Schuit FC; Derde MP; Pipeleers DG
Diabetologia; 1989 Mar; 32(3):207-12. PubMed ID: 2568961
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
Garsky VM; Clark DE; Grant NH
Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin analogs with improved oral bioavailability.
Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
[TBL] [Abstract][Full Text] [Related]
32. Conformational modifications of cyclic hexapeptide somatostatin analogs.
Freidinger RM; Perlow DS; Randall WC; Saperstein R; Arison BH; Veber DF
Int J Pept Protein Res; 1984 Feb; 23(2):142-50. PubMed ID: 6142021
[TBL] [Abstract][Full Text] [Related]
33. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin, basic and clinical studies. A review.
Schally AV; Meyers CA
Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
[No Abstract] [Full Text] [Related]
36. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
Taborsky GJ; Smith PH; Porte D
Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
[TBL] [Abstract][Full Text] [Related]
37. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.
Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH
Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin agonists and antagonists--peptide control of growth hormone secretion.
Coy DH; Murphy WA; Lance VA; Hocart SJ; Sueiras-Diaz J; Mezo I
Adv Exp Med Biol; 1985; 188():325-37. PubMed ID: 2863940
[No Abstract] [Full Text] [Related]
40. Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
Brown MP; Coy DH; Gomez-Pan A; Hirst BH; Hunter M; Meyers C; Reed JD; Schally AV; Shaw B
J Physiol; 1978 Apr; 277():1-14. PubMed ID: 349135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
